Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications After Biopsy?

Overview

Journal Adv Urol

Publisher Wiley

Specialty Urology

Date 2017 Jan 19

PMID 28096812

Authors

Erdal Benli

Abdullah Cirakoglu

Ercan Ogreden

Yeliz Cetinkol

Mustafa Kerem Calgin

Ali Ayyildiz

Ahmet Yuce

Affiliations

Soon will be listed here.

Abstract

. The aim of this study is to evaluate whether leaving the biopsy needle used during prostate needle biopsy in 10% povidone-iodine (betadine) solution affects the infectious complications forming after biopsy. . This study retrospectively evaluated the data of 176 patients with prostate biopsy performed between December 2012 and April 2014. Patients in Group 1 ( = 89) were given ofloxacin as a prophylactic antibiotic before biopsy. Patients in Group 2 ( = 87) had the biopsy needle left in povidone-iodine solution for 1 minute before each use, in addition to antibiotic prophylaxis. The two groups were compared in terms of infective complications developing after biopsy. Results were analyzed using the Mann-Whitney test and Fisher's exact test. . The distribution of infective complications after biopsy according to group was as follows. Group 1, not using betadine, had 15.7% fever, 13.5% hospital stay, 12.4% urinary retention, 10.1% prostatitis, and 5.6% sepsis. The distribution of the same complications in Group 2 using betadine was identified as 5.7% fever, 4.6% hospital stay, 3.4% urinary retention, 2.3% prostatitis, and 0% sepsis. The use of betadine was found to significantly reduce the infectious complications after biopsy compared to the control group ( < 0.05). . At the end of this study leaving the prostate needle in povidone-iodine solution before each use during prostate biopsy was found to reduce the infective complications and hospital stay after biopsy.

References

Djavan B, Waldert M, Zlotta A, Dobronski P, Seitz C, Remzi M . Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001; 166(3):856-60. View

Kanjanawongdeengam P, Viseshsindh W, Santanirand P, Prathombutr P, Nilkulwattana S . Reduction in bacteremia rates after rectum sterilization before transrectal, ultrasound-guided prostate biopsy: a randomized controlled trial. J Med Assoc Thai. 2010; 92(12):1621-6. View

Bruyere F, DArcier B, Boutin J, Haillot O . Is urine culture routinely necessary before prostate biopsy?. Prostate Cancer Prostatic Dis. 2010; 13(3):260-2. DOI: 10.1038/pcan.2010.8. View

Puig J, Darnell A, Bermudez P, Malet A, Serrate G, Bare M . Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary?. Eur Radiol. 2006; 16(4):939-43. DOI: 10.1007/s00330-005-0076-2. View

Pinkhasov G, Lin Y, Palmerola R, Smith P, Mahon F, Kaag M . Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases. BJU Int. 2012; 110(3):369-74. DOI: 10.1111/j.1464-410X.2011.10926.x. View

Batura D, Gopal Rao G, Nielsen P . Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy. BJU Int. 2010; 106(7):1017-20. DOI: 10.1111/j.1464-410X.2010.09294.x. View

Livermore D, James D, Reacher M, Graham C, Nichols T, Stephens P . Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis. 2002; 8(5):473-8. PMC: 2732494. DOI: 10.3201/eid0805.010204. View

Taylor A, Zembower T, Nadler R, Scheetz M, Cashy J, Bowen D . Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol. 2012; 187(4):1275-9. DOI: 10.1016/j.juro.2011.11.115. View

Kehinde E, Al-Maghrebi M, Sheikh M, Anim J . Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. J Urol. 2012; 189(3):911-5. DOI: 10.1016/j.juro.2012.08.237. View

10.

Chiang I, Chang S, Pu Y, Huang K, Yu H, Huang C . Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in taiwan. J Formos Med Assoc. 2007; 106(11):929-34. DOI: 10.1016/S0929-6646(08)60063-7. View

11.

Wolf Jr J, Bennett C, Dmochowski R, Hollenbeck B, Pearle M, Schaeffer A . Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol. 2008; 179(4):1379-90. DOI: 10.1016/j.juro.2008.01.068. View

12.

Zaytoun O, Anil T, Moussa A, Jianbo L, Fareed K, Stephen Jones J . Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors. Urology. 2011; 77(4):910-4. DOI: 10.1016/j.urology.2010.12.033. View

13.

Carignan A, Roussy J, Lapointe V, Valiquette L, Sabbagh R, Pepin J . Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?. Eur Urol. 2012; 62(3):453-9. DOI: 10.1016/j.eururo.2012.04.044. View

14.

Koc G, Un S, Filiz D, Akbay K, Yilmaz Y . Does washing the biopsy needle with povidone-iodine have an effect on infection rates after transrectal prostate needle biopsy?. Urol Int. 2010; 85(2):147-51. DOI: 10.1159/000314340. View

15.

Jeon S, Woo S, Hyun J, Choi H, Chai S . Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology. 2003; 62(3):461-6. DOI: 10.1016/s0090-4295(03)00470-9. View

16.

Gyorfi J, Otteni C, Brown K, Patel A, Lehman K, Phillips B . Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infectious complications following ultrasound-guided needle biopsy of the prostate. World J Urol. 2014; 32(4):905-9. DOI: 10.1007/s00345-014-1291-8. View

17.

Park D, Oh J, Lee J, Jang W, Hong Y, Hong S . Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol. 2009; :750598. PMC: 2673474. DOI: 10.1155/2009/750598. View

18.

Zani E, Clark O, Rodrigues Netto Jr N . Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011; (5):CD006576. DOI: 10.1002/14651858.CD006576.pub2. View

19.

Carey J, Korman H . Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?. J Urol. 2001; 166(1):82-5. View

20.

Zaytoun O, Vargo E, Rajan R, Berglund R, Gordon S, Stephen Jones J . Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology. 2011; 77(5):1035-41. DOI: 10.1016/j.urology.2010.12.067. View